![Insights from ESMO Breast 2024 Annual Meeting](http://media.vumedi.com/thumbs/channel_logo/2024/5/1d80b236-13c0-4fa8-821d-d5fd0ca55254.png.200x0_q85.png)
Insights from ESMO Breast 2024 Annual Meeting
ESMO Breast 2024 Insights: "CAPItello-291 Trial PFS2 & TFSC Updates - Capivasertib & Fulvestrant for Patients With Aromatase Inhibitor-Resistant HR+/HER2- Advanced BC"
By
Insights from ESMO Breast 2024 Annual Meeting
FEATURING
Hope Rugo
By
Insights from ESMO Breast 2024 Annual Meeting
FEATURING
Hope Rugo
Login to view comments.
Click here to Login
Videos